Regional overexpression of insulin-like growth factor-I and transforming growth factor-β1 in the myocardium of patients with hypertrophic obstructive cardiomyopathy

Journal of Thoracic and Cardiovascular Surgery

Volumn 123, Issue 1, 2002, Pages 89-95

  Li, Guangming ^a   Borger, Michael A ^a   Williams, William G ^a   Weisel, Richard D ^a   Mickle, Donald A G ^a   Wigle, E Douglas ^a   Li, Ren Ke ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DISOPYRAMIDE; MESSENGER RNA; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; FEMALE; GENE SEQUENCE; HEART MUSCLE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 0036384725     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.118275     Document Type: Article

References (29)

1. Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997:350:127-33.
2. Niimura H, Bachinski LL, Sangwatanaroj, Watkins H, Chudley AE, McKenna W, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338:1248-57.
3. St John Sutton M, Epstein JA. Hypertrophic cardiomyopathy - beyond the sarcomere. N Engl J Med. 1998;338:1303-4.
4. Wigle ED, Rakowski H. Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995;97: 1680-92.
5. Li G, Li R-K, Mickle DAG, Merante F, Ball WT, Christakis GT. et al. Elevated insulin-like growth factor-I and transforming growth factor-β1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy: a possible mechanism. Circulation. 1998;98(Suppl): II144-9.
6. Li R-K, Li G, Mickle DAG. Merante F, Luss H, Rao V, et al. Overexpression of transforming growth factor-β1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation. 1997;96:874-81.
7. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 1997;59:551-71.
8. Lembo G, Hunter JJ, Chien KR. Signaling pathways for cardiac growth and hypertrophy: recent advances and prospects for growth factor therapy. Ann N Y Acad Sci. 1995;752:115-27.
9. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999;341:1276-83.
10. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 1995;95:619-27.
11. lto H, Hiroe M, Hirata Y, Tsujino M, Adachi S. Shichiri M, et al. Insulin-like growth factor-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation. 1993;87:1715-21.
12. Pauliks LB, Cole KE, Mergner WJ. Increased insulin-like growth factor-1 protein in human left ventricular hypertrophy. Exp Mol Pathol. 1999:66:53-8.
13. Decker RS, Cook MG, Behnke-Barclay M. Decker ML. Some growth factors stimulate cultured adult rabbit ventricular myocyte hypertrophy in the absence of mechanical loading. Circ Res. 1995:77:544-55.
14. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1. fibronectin, and collagen. Am J Physiol. 1992;262:H1861-6.
15. Donohue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein JA. et al. Induction of myocardial insulin-like growth factor-1 gene expression in left ventricular hypertrophy. Circulation. 1994:89:799-809.
16. Ebensperger R, Acevedo E, Melendez J, Corbalan R, Acevedo M, Sapag-Hagar M, et al. Selective increase in IGF-I in a rat model of ventricular hypertrophy. Biochem Biophys Res Commun. 1998;243:20-4.
17. Williams WG, Ralph-Edwards AC, Wigle ED. Surgical management of hypertrophic obstructive cardiomyopathy. Cardiol Rev. 1997;5:40-9.
18. Duerr RL, McKiman D, Gim RD, Clark RG, Chien KR, Ross J Jr. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation. 1996; 93:2188-96.
19. Delaughter MC, Tagget GE, Fiorotto ML, Entman ML, Schwartz RJ. Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. FASEB J. 1999;13:1923-9.
20. Butt RP. Bishop JE. Mechanical load enhances the stimulatory effect of serum growth factors on cardiac fibroblast procollagen synthesis. J Mol Cell Cardiol. 1997;29:1141-51.
21. Jalil JE, Ebensperger R, Melendez J. Acevedo E, Sapag-Hagar M, Gonzalez-Jara F, et al. Effects of antihypertensive treatment on cardiac IGF-I during prevention of ventricular hypertrophy in the rat. Life Sci. 1999;64:1603-12.
22. Donohue TJ, Dworkin LD, Ma J, Lango MN, Catanese VM. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-1. J lnvestig Med. 1997;45:584-91.
23. Diez J, Laviades C. Insulin-like growth factor-1 I and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril. J Hypertens. 1994:12:s31-6.
24. Serneri GG, Modesti PA, Boddi M, Cecioni I, Paniccia R, Coppo M, et al. Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res. 1999;85:57-67.
25. Fujiwara H, Hoshino T, Yamana K, Fujiwara T, Furuta M, Hamashima Y, et al. Number and size of myocytes and amount of interstitial space in the ventricular septum and in the left ventricular free wall in hypertrophic cardiomyopathy. Am J Cardiol. 1983;52:818-23.
26. Tanaka M, Fujiwara H, Kawai C. Pathological features of hypertrophic cardiomyopathy without asymmetrical septal hypertrophy. Br Heart J. 1986;56:294-7.
27. Reiss K. Cheng W, Ferber A, Kajstura J, Li P, Li B, et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U SA. 1996;93:8630-5.
28. Knight C. Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation. 1997;95:2075-81.
29. Villarreal DJ, Lee AA, Dillmann WH, Giordano FJ. Adenovirus-mediated overexpression of human transforming growth factor-beta 1 in rat cardiac fibroblasts, myocytes and smooth muscle cells. J Mol Cell Cardiol. 1996;28:735-42.